Versor Investments LP Has $717,000 Stake in Maximus, Inc. (NYSE:MMS)

Versor Investments LP boosted its holdings in Maximus, Inc. (NYSE:MMS) by 12.9% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 9,600 shares of the health services provider’s stock after purchasing an additional 1,100 shares during the quarter. Versor Investments LP’s holdings in Maximus were worth $717,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of the business. UMB Bank n.a. raised its stake in Maximus by 79.8% in the 4th quarter. UMB Bank n.a. now owns 356 shares of the health services provider’s stock worth $27,000 after purchasing an additional 158 shares in the last quarter. V Square Quantitative Management LLC raised its position in shares of Maximus by 65.9% in the 4th quarter. V Square Quantitative Management LLC now owns 453 shares of the health services provider’s stock valued at $34,000 after buying an additional 180 shares in the last quarter. Petrus Trust Company LTA raised its position in shares of Maximus by 2.7% in the 3rd quarter. Petrus Trust Company LTA now owns 7,084 shares of the health services provider’s stock valued at $660,000 after buying an additional 185 shares in the last quarter. Holocene Advisors LP raised its position in shares of Maximus by 6.5% in the 3rd quarter. Holocene Advisors LP now owns 3,927 shares of the health services provider’s stock valued at $366,000 after buying an additional 239 shares in the last quarter. Finally, MML Investors Services LLC raised its position in shares of Maximus by 6.5% in the 3rd quarter. MML Investors Services LLC now owns 4,870 shares of the health services provider’s stock valued at $454,000 after buying an additional 299 shares in the last quarter. Institutional investors and hedge funds own 97.21% of the company’s stock.

Insiders Place Their Bets

In other Maximus news, insider Ilene R. Baylinson sold 14,500 shares of the business’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total transaction of $988,030.00. Following the sale, the insider now directly owns 2,512 shares of the company’s stock, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, insider Michelle F. Link sold 2,208 shares of the business’s stock in a transaction that occurred on Tuesday, December 3rd. The stock was sold at an average price of $73.83, for a total transaction of $163,016.64. Following the sale, the insider now directly owns 6,567 shares in the company, valued at $484,841.61. The trade was a 25.16 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 1.60% of the company’s stock.

Maximus Trading Down 2.2 %

Shares of Maximus stock opened at $65.02 on Friday. The firm has a market capitalization of $3.68 billion, a PE ratio of 13.98 and a beta of 0.72. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm’s 50 day moving average is $73.45 and its 200 day moving average is $81.14. Maximus, Inc. has a 1 year low of $63.77 and a 1 year high of $93.97.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.39 by $0.22. Maximus had a net margin of 5.28% and a return on equity of 21.95%. Equities research analysts forecast that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, February 28th. Shareholders of record on Saturday, February 15th were issued a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 1.85%. The ex-dividend date was Friday, February 14th. Maximus’s payout ratio is 25.81%.

Wall Street Analyst Weigh In

MMS has been the subject of several analyst reports. StockNews.com cut shares of Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th. Raymond James upgraded shares of Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 target price for the company in a research report on Thursday, January 2nd.

Maximus Company Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.